E. Theodoropoulou et D. Marsh, Effect of angiotensin II non-peptide AT(1) antagonist losartan on phosphatidylethanolamine membranes, BBA-BIOMEMB, 1509(1-2), 2000, pp. 346-360
Losartan was found to affect both the thermotropic behavior and molecular m
obility of dimyristoyl- and dipalmitoylphosphatidylcholine membranes (Theod
oropoulou and Marsh, Biochim. Biophys. Acta 1461 (1999) 135-146). At low co
ncentrations, the antagonist is located close to the interfacial region of
the phosphatidylcholine bilayer while at high mole fractions it inserts dee
per in the bilayers. In the present study, we investigated the interactions
of losartan with phosphatidylethanolamine membranes using differential sca
nning calorimetry (DSC), electron spin resonance (ESR) and P-31 nuclear mag
netic resonance (NMR) spectroscopy. DSC showed that the antagonist affected
the thermotropic transitions of dimyristoyl-, dipalmitoyl- and dielaidoyl-
phosphatidylethanolamine membranes (DMPE, DPPE and DEPE, respectively). ESR
spectroscopy showed that the interaction of losartan with phosphatidyletha
nolamine membranes is more superficial than in the case of phosphatidylchol
ine bilayers. Additionally, losartan increased the spin-spin broadening of
12-PESL spin labels in the gel phase of DMPE and DPPE membranes, while in t
he case of DEPE membranes the opposite effect was observed. P-31-NMR showed
that the antagonist stabilizes the fluid lamellar phase of DEPE membranes
relative to the hexagonal HII phase. Our results show that losartan affects
the thermotropic behavior of phosphatidylethanolamine membranes, while the
molecular mobility of the membranes is not affected greatly. Furthermore,
its interactions with phosphatidylethanolamine membranes are more superfici
al than with phosphatidylcholine bilayers. (C) 2000 Elsevier Science B.V. A
ll rights reserved.